Market Focus and Product Development - The rat control market is considered sufficient for the company's near-term focus[18]. - The company is focused on gaining market acceptance and commercial viability for its products, including ContraPest and Evolve[18]. - The company believes that its technology can be applied to other mammalian species, which may open new market opportunities[21]. - The company expects expenses to continue increasing as commercialization activities advance[18]. - The success of the company's research and development efforts is critical for future performance and product commercialization[21]. Regulatory and Compliance Issues - The company acknowledges the risks associated with obtaining regulatory approval for its product candidates[21]. - The company anticipates that first and second generation anti-coagulant rodenticides will face increased scrutiny and potential restrictions[18]. - The company asserts that Evolve qualifies for exemption from registration as a minimum risk pesticide under EPA regulations[18]. - The company is subject to compliance with Nasdaq's continued listing requirements, which is vital for maintaining its market presence[21]. - The company files reports with the SEC, ensuring transparency and compliance with information requirements[23]. Financial and Operational Risks - The company faces risks that may cause actual results to differ materially from forward-looking statements, including market acceptance of products and regulatory approvals[21]. - The company acknowledges potential product liability lawsuits that could incur substantial liabilities and limit product commercialization[21]. - The company is concerned that raising additional capital may dilute existing stockholders and restrict operations[21]. - The company recognizes that its share price is volatile, which could lead to securities class action litigation[21]. Human Resources and Talent Management - The company plans to utilize stock-based awards to attract and retain talented employees[18]. - Retaining and attracting key personnel is essential for the company's growth and operational development[21]. - The company emphasizes the importance of establishing an effective sales force and marketing infrastructure to generate significant revenue[21]. Research and Field Studies - The company believes that field research demonstrates more than 90% reduction in rat populations when integrated with pest management protocols[18]. - The company aims to establish fertility control as a standard tool in pest management across all verticals[18].
SenesTech(SNES) - 2024 Q4 - Annual Report